MHRA (UK) · Jun 5, 2026
Notice: Medicines: terminated and cancelled manufacturing and wholesale dealer licences
UK companies who have their licence to manufacture or wholesale medicines terminated and cancelled.
Global Health · page 26
UK, EU & international health agencies
MHRA (UK) · Jun 5, 2026
Decision: Human medicines: register of licensed wholesale distribution sites
Department of Health and Social Care and MHRA register of licensed wholesale distribution sites (human).
MHRA (UK) · Jun 5, 2026
MHRA review of the benefits and risks of avacopan
Avacopan is used in the treatment of some rare autoimmune diseases affecting small blood vessels.
DHSC (UK) · Jun 5, 2026
Guidance: DHSC public appointments: 2026 to 2027
Non-executive appointments to the Department of Health and Social Care's public bodies and committees from April 2026 to March 2027.
DHSC (UK) · Jun 5, 2026
Research: Housing and health in local strategic health planning
Findings from a national review of how housing features in local strategic health planning documents in England.
MHRA (UK) · Jun 5, 2026
Field Safety Notices: 18 -22 May 2026
List of Field Safety Notices for 18 -22 May 2026
UKHSA (UK) · Jun 5, 2026
Guidance: Vaccination of individuals with uncertain or incomplete immunisation
One-page summary for health professionals and immunisation practitioners giving vaccinations.
UKHSA (UK) · Jun 5, 2026
Hantaviruses
The characteristics, diagnosis, epidemiology of hantaviruses.
UKHSA (UK) · Jun 4, 2026
Research: Outbreaks under monitoring in 2026
Latest information on global disease events under monitoring.
UKHSA (UK) · Jun 4, 2026
Guidance: NRRW: employment and follow-up information
Employers provide records of employment episodes, occupational exposure to ionising radiation and some personal identifying data.
UKHSA (UK) · Jun 4, 2026
Guidance: MenB vaccine and paracetamol
Information about the meningococcal B (MenB) vaccine and paracetamol use.
MHRA (UK) · Jun 4, 2026
Adjuvanted trivalent influenza vaccine authorised for adults aged 50 and over
The adjuvanted trivalent influenza vaccine works by stimulating the immune system to produce its own protection against flu.
MHRA (UK) · Jun 4, 2026
Research: MHRA Public Sector Equality Duty Report 2025-2026
MHRA’s Public Sector Equality Duty report 2026 sets out progress on equality, diversity and inclusion across regulation, public engagement and workforce.
UKHSA (UK) · Jun 4, 2026
Research: Notifiable diseases: causative agents reports for 2026
Weekly data from UK laboratories on the number of cases of notifiable bacteria and viruses (see important note in Details section, below).
UKHSA (UK) · Jun 4, 2026
Guidance: Influenza, COVID-19 and other respiratory viruses: sources of surveillance data
Sources of data for the surveillance systems used to monitor COVID-19, influenza and other seasonal respiratory viruses in England.
UKHSA (UK) · Jun 4, 2026
Research: GP out-of-hours syndromic surveillance: weekly bulletins for 2026
The number of people contacting their GPs outside of surgery hours under the syndromic surveillance system.
UKHSA (UK) · Jun 4, 2026
Research: Syndromic surveillance: weekly summaries for 2026
This weekly summary highlights changes in the number of people visiting GPs, going to emergency departments and calling NHS 111.
UKHSA (UK) · Jun 4, 2026
Research: National ambulance syndromic surveillance: weekly bulletins 2026
The number of people calling ambulances each day, with results published every week under the syndromic surveillance system.
UKHSA (UK) · Jun 4, 2026
Official Statistics: Weekly all-cause mortality surveillance: 2025 to 2026
How the actual number of deaths in England compare with the expected numbers of deaths for each week.
UKHSA (UK) · Jun 4, 2026
Research: Remote health advice: weekly bulletins for 2026
Summary of the number of people calling NHS 111 for health advice within England on a weekly basis under the syndromic surveillance system.
UKHSA (UK) · Jun 4, 2026
Official Statistics: National flu and COVID-19 surveillance reports: 2025 to 2026 season
National influenza (flu) and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.
DHSC (UK) · Jun 4, 2026
Policy paper: Government response to the Lord Mann review on antisemitism and other forms of racism in the NHS
The government response to the Lord Mann review into antisemitism and other forms of racism in the NHS.
DHSC (UK) · Jun 4, 2026
Independent report: Lord Mann review on antisemitism and other forms of racism in the NHS
An urgent review led by Lord John Mann examining how the NHS, including employers and UK health regulators, identify, report and respond to antisemitism and other forms of racism.
DHSC (UK) · Jun 4, 2026
Lord Mann's recommendations to tackle antisemitism accepted
Government to act on Lord Mann’s report about tackling racism and antisemitism in the NHS.